| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c1dae008baa5e165bff1b8a6178aafa7 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2565-627
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2535-125
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-156
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-112
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-382 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6872
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6816
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6883 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H21-04 |
| filingDate |
2014-05-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2016-01-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bb8d06387fd8ef1fb3a92bf41f5b167a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3009c9393f4c3c82bd9b7b9286cabb6a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ad282fa593a92bd3868d96763ebc87f0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_63d65b45f4642835c6dd533d25af1dae
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_18a6a0a7659c83f313e1b51b673c895a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_da4e69521efb487f3380cb0f21cc4302 |
| publicationDate |
2016-01-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-9234243-B2 |
| titleOfInvention |
Mutations associated with cystic fibrosis |
| abstract |
The present invention provides novel mutations identified in the cystic fibrosis transmembrane conductance regulator (CFTR) gene that can be used for a more accurate diagnosis of cystic fibrosis (CF) and CF related disorders. Methods for testing a sample obtained from a subject to determine the presence of one or more mutations in the CFTR gene are provided wherein the presence of one or more mutations indicates that the subject has CF or a CF related disorder, or is a carrier of a CFTR mutation. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10865450-B2 |
| priorityDate |
2010-03-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |